Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more
Episode Description
May 09, 2017 edition of the weekly JAMA Editors' Summary
We use cookies to run this site. Analytics cookies help us understand how you use it and are off until you say yes. You can change your mind at any time from the privacy preferences icon at the bottom right.We use cookies to run this site and to understand how it's used. You can opt out at any time from the privacy preferences icon at the bottom right. Cookie policy